|Bid||15.00 x 1000|
|Ask||19.49 x 1000|
|Day's Range||18.55 - 18.88|
|52 Week Range||4.97 - 18.98|
|Beta (3Y Monthly)||2.98|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So we'll take a look a...
Catasys Inc is a healthcare services company, provides health services designed to assist health plans & employees to manage & treat their high cost substance dependence members through a network of healthcare providers & its employees. Catasys Inc had annual average EBITDA growth of 56.10% over the past ten years. Warning! GuruFocus has detected 5 Warning Signs with CATS.
Terren Peizer has been the CEO of Catasys, Inc. (NASDAQ:CATS) since 2003. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth thatRead More...
If you want to know who really controls Catasys, Inc. (NASDAQ:CATS), then you'll have to look at the makeup of its share registry. Institutions often own shares in more established Read More...
For more speculative investors, one of my favorite stocks in our newsletter portfolio as 2019 gets underway is Catasys (CATS), explains Nate Pile, a growth stocks expert editor of Nate's Notes.
Catasys (CATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This analysis is intended to introduce important early concepts to people who are starting to invest and want to better understand how you can grow your money by investing inRead More...